Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-27 · accession 0001069530-22-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-31 | 2022-05-27 | FLNA | FRIEDMANN NADAV | Chief Medical Off, Dir | F - Tax | $26.66 | -24.6K | 70.5K | -26% | -$655.0K |
| DM | 2022-05-31 | 2022-05-27 | FLNA | FRIEDMANN NADAV | Chief Medical Off, Dir | M - OptEx | $23.38 | +28.0K | 70.6K | +66% | +$655.0K |
| DM | 2022-05-31 | 2022-05-27 | FLNA | FRIEDMANN NADAV | Chief Medical Off, Dir | M - OptEx | $23.38 | -28.0K | 0 | -100% | -$655.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | F | D | 3,071 | $26.66 | 92,032 | D | — | — | (F1) Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. |
| 2 | Common | Common Stock | 2022-05-27 | M | A | 24,513 | $23.38 | 95,103 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-27 | M | A | 3,501 | $23.38 | 70,590 | D | — | — | |
| 4 | Common | Common Stock | 2022-05-27 | F | D | 21,498 | $26.66 | 70,534 | D | — | — | (F1) Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. |
| 5 | Derivative | Common Stock | 2022-05-27 | M | D | 24,513 | $23.38 | 0 | D | $23.38 · 2016-06-08 to 2022-06-08 | 24,513 Common Stock | |
| 6 | Derivative | Common Stock | 2022-05-27 | M | D | 3,501 | $23.38 | 0 | D | $23.38 · 2016-06-08 to 2022-06-08 | 3,501 Common Stock |